Transesophageal atrial pacing or pharmacologic stress testing in detection of coronary artery disease in patients who are unable to undergo exercise stress testing  by Kotler, Morris N. & Jacobs, Larry E.
,154 
Editorial Comment __~ 
Transesophageal Atria1 Pacing or 
Pharmacologic Stress Testing in 
Detection of Coronary Artery 
Disease in Patients Who Are 
Unable to Undergo Exercise 
Stress Testing* 
MORRIS N. KOTLER, MD. FACC, 
LARRY E. JACOBS, MD 
Philndelpldo. Peansyhmio 
Dynamic exercise is the stress test of choice in assessing 
symptoms and functional capacity in patients with suspected 
or proved coronary heart disease. Exercise electroeardiog- 
raphy. radianuclide angiogruphy. thallium-201 scintigraphy 
and twa-dimensional echocardiography provide diagnustic 
information. as well as prognostic risk assessment. I” pa- 
tients unable to exercise adequately because of severe 
peripheral vascular disease, arthritis, fracture, “euromuscu- 
lar weakness, obesity. chronic obstructive pulmonary dis- 
ease, advanced age or generalized weakness, as well as 
those recovering from surgery. alternative forms of testing 
are required for the evaluation of the physiologic extent of 
coronary artery disease (I). In addition. in patients who are 
unable to cooperate during exercise stress testing or in 
unmotivated patients. detection of coronary anery disease 
must be assessed by other means. Although environmental 
stress tests including the cold pressor test, isometric hand- 
grip exercise and arm ergumetry have been proposed (I). the 
two uw frequently used tests are atrial pacing and phar- 
macologic stress testing utilizing dipyridamale. dobutamine 
or adenostne. 
Atrial pacing. In 1967 Sowton cl al. (2) introduced tight 
atria1 pacing as a stress test for assessing the presence and 
severby of coronary artery disease. Since then, several 
investigators (3.4) have utilized the ability to control in- 
creates in heart rate by “acing techniques to precipitate 
coronary insufficiency. 
Atrial pacing produces minimal or no change in systolic 
or diastolic blood pressure: thus, the rate-pressure product is 
less with atrial pacing than that obtained during exercise 
testing (5). Despite this limitation. several investigators 
(6-1 I) have demonstrated similar sensitivity and specificity 
fur strial pacing and exercise testing in the detection of 
coronary artery disease. Atrial pacing producer a decrease 
in left ventricular end-diastolic pressure during maximal 
pacing tachycardia nd in the immediate period after pacing 
in “omml subjects. In contrast, in patients with coronary 
disease there is no change or a slight increaSe in left 
ventricular end-diastolic pressure during maximrl ,+acing tu 
angina and a marked increase immediately after I ,cing (4). 
Some investigators (4) have also demonstrated th.:t cardiac 
output may decrease and systemic vascular resist.xtce may 
increase. 
Transesophogeolpacing of rhe left atrium has dlso been 
described with use of a standard transvenous wlheter or 
bipular catheter that is passed into the esophzgus in a 
manner similar tu “asoaastric tube insertion (9.10) or in a 
special gelatin capsule that encases a bipolar electrode that is 
swallowed (I I). Pacing is usually started at 80 to 100 
beatslmin and increased by IO to 20 beats:min every I to 3 
min. End points for the test include achievement ofa target 
rate (140 to I50 beats/pi”) or 80% to IOU% of the age- 
predicted maximal heart rat<. phest pain or marked (a2 mm) 
ST depression (I). However, the development of horizontal 
or downsloping ST depression rl mm at 0.08 atler the J 
point defines a” ischemic response (I). I” some patients who 
develop atrioventricular (AV) Wettckebach block, adminis- 
tration of intravenous atropine (0.5 to 1.0 mg) may improve 
AV ““de conduction and achievement of a increased heart 
rate. Hypokalemia, digitalis, left bundle branch block and 
!eft ventricular hypeflrophy may produce a false positive 
electrocardiogmuhic (ECG) response (I). In addition. false 
positive ST &p&ion may occur in patients with normal 
coronary arteries at very high pacing rates, generally 2180 
beatslmin (1). 
Electmcardiographic responses, derangements of myo- 
cardial lactate metabolism and regional wall motion abnor- 
malities have all been wnsidered end points (I). Increased 
sensitivity of tbe ECG alone has been repotted (6) with use 
of a 12 lead ECG recorder and attention paid to the duration 
of the pacing test. A” increase in the sensitivity and speci- 
ficity of atrial pacing in detecting significant coronary artery 
disease has been obtained when cardiac imaging techniaues 
we also employed (9.10). Advantages of at&l~aci”g t&h- 
niques include the ability to abruptly stop the test when end 
points are achieved, which is especially important in patients 
who develop ischemia. Disadvantages include the develop 
ment of AV node block in some patients and chest or 
esophageal pain as a result of esophageal pacing. 
The wesent shuiv. In this issue of the Journal. Lanbertr 
et al. ((2) describe H technique utilizing simultaneous trans. 
esophageal atrial pacing and transesophageal two-dimen- 
sional echocardiography in evaluating patients with core- 
nary artery disease. The advantage of their new instrument 
is the ability to perform transesophageal echocardiography 
with simultaneous transewphageal atrial pacing by means of 
the same probe and requiring only one insertion of the probe 
into the ‘esophagus and stomach. High resobmon two- 
dimensional echocardiographic images were obtained in 
100% of patients and baseline studies were compared with 
images obtained during maximal atrial pacing utilizing a tine 
loop format. The disadvantages include the passage of a 
large probe into the esophagus with all the precautions and 
complications inherent in transesuphageal echocardiog- 
raphy. In addition, chest pain or discomfort dw to eropha- 
geal pacing occurred in five parienrs. However. the main 
disadvantage appears to be the limited chart-axis views of 
the left ventricle obtained at the midpapillary muscle Iwel. 
In patients with mid or distal vessel disease. wall motion 
abnomtalities may not he detected by the single. limited 
short-axis view of the left ventricle.. In addition. for an 
individual patient. coronary anaIomy may overlap terrilorial 
supply and precise idemificmion of the culprit obstructed 
coronary vessel may not be possible. Despite these limifa- 
lions. the ability to utilize: different views and image Qbmes. 
as well as ihe use of biphne and multiplane transesophageal 
echocardiography. will enhsnce the visualization of all wall 
segments. The results of the study by Lamhcnz et al. (12) 
utilizing this technique is compared with some recent studies 
with atrial pacing (Table t). 
Cornpnrison of Atriul Pacing With 
Phnrrnacologic Stress Testing 
Diwridsmole (Persanline) lhailiumdOl scinti?_raphy and 
two.di&sional echocardiography. Dipyridamolc is used 
frequently for assessing the presence and extent of coronary 
anery obstruction (13-23). With dipyridamole and both 
imaging techniques the reported sensitivity and specificity 
have been reported to range between 80% and 90% 124). In 
addition. dlpyridamole thallium-XI scinligraphy or !WO- 
dimensional echocardiography has provided useful prognos- 
!Ic information in postmyocardial mfarction patients. (?Jt as 
well as in patients with coronary anay disease undergoing 
risk assessment before peripheral vascular or aortic surgery 
(25-28). Dipyridamolc increases peak coronary blood Row 
fivefold in normal arteries, as well as in arteries with mild or 
moderate stenosis (23). The increase in blood flow proxirozl 
to a coronas lesion is associated with an increase in 
prersure gradient across the stenosis and a drop in pressure 
distally (23). Subendosardial Row is relatively less than 
epicardial flow, resulting in relative hypopelfusion of areas 
of myocardium supplied by a stenotic artery compared with 
those segments upplied by a nomml or less stenotic vessel. 
The inhomogeneity of Row is detected by abnormal 
thallium uptake when tracer thallium-201 is injected during 
the peak vasodilative ffect of the drug. In contrast. regional 
wall motion abnormalities detected by twodimensional 
echocardiography occor as a result of ischemic changes in 
wall motion due to its unique pharmacologic action. The 
coronary vasodilating action occurs as a result of inhibition 
of myocardial adenosinc and capillary endothelial transport 
of endogenously produced adenorine (23). The usual dose of 
dipyridamole is 0.56 m&kg body weight infused intrave- 
nously over4 min or3OOto 403 mggiven orally (23.24). Both 
methods of delivery yield comparable scintigmphic results 
but headache and nausea with oral dipyridamole occur more 
frequently (30). More recently the dose of dipyridamole has 
been increased to O.t?4 mgikg over IO mitt with improved 
sensitivity and no chacge in specificity (23). Side effects with 
dipyridamole occur in many patients. In a recent study (30) 
of 3.911 patients, major adverse reactions were rare and 
occurred in IO patients (0.26%). Fatal and nonfatal myoar- 
dial infarction and asthmatic attacks were considered seri- 
ous: the acote bronchosoasm was reversed in all instances 
by intravenous aminophylline (30.31). Minor side effects 
included chest pain (29.741, headache (12.2%). dizziness 
(ll.S%L ECG ST segment changes (7.5%). nausea (4.6%) 
and hypotension (4.6%) (31,321. Ninety-seven percent of 
pat& receiving aminophylline had pr&npt r&f of these 
side effects. Despite widespread use of dipyridamok stress 
testing, the Food and Drug Administration still has not 
approved i! for clinical use. 
Adenosine. More recently. adenosine and thallium-201 
scintigraphy have been advocated for patients unable to 
exercise (32). Dosages of 50 &kg perlmin increasing up to 
I40 &kg perlmin were infused. Side effects occurred in 83% 
of patients and included chest, throat and jar pain, head- 
ache, flush, ischemic ECG changes ana transient AV block. 
.All side effects resolved within I to 2 min and no patient 
required aminophylline. Sensitivity was 83% and specificity 
was 94% for detection of coronary artery disease. 
Dobutamine stress testing. Dobutamine is a potent stim- 
ulator of beta,. beta, and alpha,-adrenoreceptors with pre- 
dominant inotropic and some chronotropic activity (33-35). 
It is now regarded as a form of a pharowologic exe:cise test 
because it increases contractility. systolic blood pressure 
and heart rate at higher doses, thereby provoking myacardial 
ischemia (36,37). Although dobutamine produces similar 
inhomogeneity of coronary blood flow in patients with 
coronary stenotic lesions as compared with dipyridamole 
infused intravenously, it also increases the rate-pressure 
product and myocardial oxygen demand as compared with 
dipyridamole administered intravenously (35). The sensitiv- 
ity and specificity of dobutamine stress testing have been 
reported to range between 9V% and 80%. respectively 
(37.38). 
The advanroges of dobutamine include easy administra- 
tion and rapid onset and cessation of action. Results of its 
use are not influenced by patient motivation or ability to 
exercise and the hemodynamic response can be controlled 
(35). The study can be immediately terminated when ixhe- 
mic regional wall motion abnormalities are recognized by 
two.dimensional echocardiography, thus avoiding serious 
side effects. Disadvantages include ventricular arrhythmias, 
significant sinus tachycardia. nausea and tremor and marked 
ST depression in some patients (37). Minor symptoms, such 
as palpitation, headache, paresthesia and a cold or hot 
feeling, have been reported that generally disappear 
promptly when the medication is stopped. The starting dose 
of dobutamine given intravenously is 5 &kg per min. which 
can then be increased to IO. IS and 20 &g per min every 
3 to 5 min: rarely. 40 p&g per min had to be used to 
increw heart rate at rest by at least 20 beatslmin or 
achievement of 85% of maximal predicted heart rate (37). 
Intravenous administration of atropine has been recom- 
mended if heart rate response is inadequate; if severe 
ischemia occurs. it can be rapidly reversed with intravenous 
infusion of esmolol. 
Conelusions. Avarietyof stress testsare availableforthe 
detection of coronary artery disease in patients who are 
unable to undergo dynamic exercise testing. Esophageal 
atrial pacing with simultaneous transesapha8eal detection of 
wall motion abnormalities has a high sensitivity and speci- 
ficity in detectingcoronary artery disease. Because adequate 
images are obtained in 100% of patients using transesoph- 
ages1 two-dimensional echccardiogmphy. the technique 
should be employed in patients with unsatisfactory images 
obtained during transthoracic echocardiagraphic stress 
tests. Further studies are needed with larger numbers of 
patients to compare esophageal pacing echocardiography 
with pharmacologic stress testing in the detection of core- 
nary artery disease in patients unable to undergo exercise 
stress testing. 
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